What type of study is this?

This is a Cox Regression study.

September 5, 2025HemaSphereOpen Access

Results in pediatric T‐ALL patients treated in trial AIEOP‐BFM ALL 2009: Prognostic factors in the context of modern risk‐adapted therapy

View Full Paper

Ask AI

Bookmark

Authors

Trial AIEOP‐BFM ALL 2009 evaluates treatment outcomes in pediatric T‐ALL patients, revealing critical prognostic factors.

Five-year event-free survival (EFS) reached 79.9%, with high-risk patients showing significantly lower success rates.
High PCR-based minimal residual disease (MRD) levels were strong prognostic indicators, influencing treatment stratification.
Cox regression models identified factors like CNS3 involvement and EOI-MRD as crucial in determining patient outcomes.
The study emphasizes the importance of predictive factors for future treatment protocols in pediatric T‐ALL management.

Cario et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

September 5, 2025HemaSphereOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Trial AIEOP‐BFM ALL 2009 evaluates treatment outcomes in pediatric T‐ALL patients, revealing critical prognostic factors.

Five-year event-free survival (EFS) reached 79.9%, with high-risk patients showing significantly lower success rates.
High PCR-based minimal residual disease (MRD) levels were strong prognostic indicators, influencing treatment stratification.
Cox regression models identified factors like CNS3 involvement and EOI-MRD as crucial in determining patient outcomes.
The study emphasizes the importance of predictive factors for future treatment protocols in pediatric T‐ALL management.

Cario et al. (2025) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark